ESTRO 2024 - Abstract Book

S2802

Interdisciplinary - Health economics & health services research

ESTRO 2024

and understand the factors contributing to the variation in treatment volumes during the pandemic e post pandemic period.

Keywords: Process mining, Covid-19

1260

Digital Poster

Interorganisational care pathways annex patient journeys in radiotherapy

Maria Jacobs 1 , Hanneke Martinussen 2 , Carol Ou 3 , Bert Meijboom 3 , Rene Monshouwer 4 , Andre Minken 5 , Evert Walrave 6 , Remco Huiszoon 7 , Geert Bosmans 2 , Judith van Loon 2 , Jolanda van Hoeve 8,9 , Luca Heising 2,10 , Ashleigh Jiminez 2 , Rachelle Swart 2 , Anne Gubbels 2 , Toine Kaas 11 , Paul Cremers 2 , Liesbeth Boersma 2 1 Tilburg University, 2. Department of Management, Tilburg School of Economics and Management, Tilburg University, Tilburg, The Netherlands, Maastricht, Netherlands. 2 Maastricht University Medical Center, Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Reproduction,, Maastricht, Netherlands. 3 Tilburg University, Department of Management, Tilburg School of Economics and Management, Tilburg University, Tilburg, The Netherlands, Tilburg, Netherlands. 4 Radboud University Medical Center, Department of Radiation Oncology, Nijmegen, Netherlands. 5 Radiotherapiegroep, Department of Radiation Oncology, Arnhem/Deventer, Netherlands. 6 Lungcancer the Netherlands, patient advocates, Utrecht, Netherlands. 7 Society of oesophageal or stomach cancer, patient advocates, Utrecht, Netherlands. 8 Netherlands Comprehensive Cancer Organisation (IKNL), Department of Research and Development, Utrecht, Netherlands. 9 University of Twente, Department of Health Technology and Services Research, Technical Medical Centre,, Enschede, Netherlands. 10 Tilburg University, 2. Department of Management, Tilburg School of Economics and Management, Tilburg University, Tilburg, The Netherlands, Tilburg, Netherlands. 11 Maastricht University Medical Center, Patient council, Maastricht, Netherlands In recent years, highly innovative treatment options such as proton therapy and magnetic resonance-guided radiotherapy have emerged. Although these techniques hold a great promise for enhancing patient outcomes, their substantial costs necessitate further research to solidify their clinical benefit (1,2). Moreover, the application of these and other intricate procedures like hyperthermia, brachytherapy, and gamma-knife, demands highly specialized skills. Currently not all radiotherapy centres are equipped with such available innovative technologies, due to, for example cost constraints, portfolio decisions and/or regulatory limitations. Nonetheless, to ensure that all patients can equally access these innovative treatments across different centres, regardless of their geographical location in a country, it is crucial to encourage collaboration between radiotherapy centres. Such a collaboration should facilitate the seamless referral of patients among centres. Furthermore, this collaboration boosts collective knowledge and has the potential to reduce healthcare costs by preventing underutilisation of expensive technologies; a scenario that might occur during the period when clinical evidence is Purpose/Objective: